Filter Results:
(4,369)
Show Results For
- All HBS Web
(4,369)
- People (14)
- News (1,531)
- Research (2,279)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,791)
Show Results For
- All HBS Web
(4,369)
- People (14)
- News (1,531)
- Research (2,279)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,791)
- July 2000 (Revised August 2005)
- Case
Deaconess-Glover Hospital (A)
Chronicles the initial efforts to teach a health care organization to manage itself according to the principles of the Toyota Production System (TPS). Describes the decision and dilemmas that arose from the implementation experiment. Builds on Bowen and Spear's earlier... View Details
Spear, Steven J., and John Kenagy. "Deaconess-Glover Hospital (A)." Harvard Business School Case 601-022, July 2000. (Revised August 2005.)
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
- September 2016
- Article
Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer
By: Nikhil G. Thaker, Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan and Steven J. Frank
Question: Can we create a value-based tool to visualize the outcomes and cost of various treatments that could facilitate patient-centered decision making?
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Thaker, Nikhil G., Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan, and Steven J. Frank. "Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer." Journal of Oncology Practice 12, no. 9 (September 2016): 813–820.
- 14 Mar 2016
- Working Paper Summaries
The Role of Incentive Salience in Habit Formation
- 25 Sep 2017
- Research & Ideas
Why Politics is Failing America, and What Business Can Do To Help
has been a major obstacle to moving the country forward on nearly every front that makes a healthy business environment, from tax reform and restoring economic growth to improving public education and View Details
Keywords: by Christina Pazzanese, Harvard Gazette
- 11 Feb 2014
- News
Thank You For Not Selling: Historian Nancy Koehn On CVS' Tobacco Ban
- June 2003 (Revised November 2003)
- Case
Siemens Medical Solutions: Strategic Turnaround
By: D. Quinn Mills and Julian Kurz
Describes how Siemens Medical Solutions (MED) accomplished a remarkable turnaround from a money-losing operation to one of Siemens' most profitable divisions. By late 1996, a challenging market environment in the health care industry as well as inefficiencies in the... View Details
Keywords: Opportunities; Globalized Firms and Management; Health Care and Treatment; Transformation; Problems and Challenges; Medical Devices and Supplies Industry
Mills, D. Quinn, and Julian Kurz. "Siemens Medical Solutions: Strategic Turnaround." Harvard Business School Case 703-494, June 2003. (Revised November 2003.)
- 01 Oct 1997
- News
Class of '97 Placement Statistics Similar for September and January Cohorts
& Media 4% Investment Management 4% Health Care 3% Consumer Products 3% Other Services 12% Other Manufacturing 3% Employment by Company Size (number of employees)** 10,001 22% * 883 students graduated in the... View Details
- 07 Jun 2016
- First Look
June 7, 2016
discontinuity design that facilitates sharper identification of treatment effects, we find a significant and discontinuous increase in tax avoidance following Russell 2000 inclusion. The tax avoidance... View Details
Keywords: Sean Silverthorne
- June 2014
- Article
Improving Value with TDABC
By: Robert S. Kaplan
The article discusses the benefits of time-driven activity-based costing (TDABC) combined with outcomes measurement for healthcare organizations. Topics covered include improving resource efficiency, optimizing care over the complete care cycle, and planning and... View Details
Keywords: Goals and Objectives; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Kaplan, Robert S. "Improving Value with TDABC." hfm (Healthcare Financial Management) 68, no. 6 (June 2014): 76–83.
- Web
Helping and harnessing business to address society’s greatest challenges. | Institute for Business in Global Society
historical perspective— innovative, disruptive, secular— continues to shape teaching, research, and multi-faculty projects at HBS today. Entrepreneurship Initiative The Arthur Rock Center for Entrepreneurship is a vital resource to HBS... View Details
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.